Joel Dore
Research Subjects
Joel Dore has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Lionel Rigottier-Gois
INRA, UMR1319 Micalis, Jouy-en-Josas, France
3 shared publications Malene Sutren
2 shared publications- Patricia Lepage
AgroParisTech, Micalis Institute, INRAE, PhylHom Lab, Université Paris-Saclay, Jouy-en-Josas, France
2 shared publications Philippe Marteau
2 shared publicationsPhilippe Pochart
2 shared publications- Philippe Seksik
Department of Gastroenterology, CRSA, FHU Gut, Liver & Microbiome Research (GLIMMER), Sorbonne Université, INSERM, APHP, Hôpital Saint-Antoine, Paris, France
2 shared publications
Latest Publications
- Open Access
- 1 December 2005
- Published by Elsevier in The Journal of Nutrition
- Vol. 135 (12) , 2786-2792
Isoflavones and Functional Foods Alter the Dominant Intestinal Microbiota in Postmenopausal Women
Dietary phytoestrogens, such as isoflavones, are used as food additives to prevent menopause-related disorders. In addition to other factors, their bioavailability strongly depends on the activity of intestinal bacteria but the underlying interactions remain poorly understood. A randomized, double-blind, placebo-controlled study was undertaken with 39 postmenopausal women to characterize changes in the dominant microbial communities of the intestinal tract after 2 mo of isoflavone supplementation with and without pro- or prebiotic. The diversity and composition of the dominant microbiota were analyzed by temporal temperature-gradient gel electrophoresis (TTGE) and fluorescent in situ hybridization. Isoflavones alone stimulated dominant microorganisms of the Clostridium coccoides-Eubacterium rectale cluster, Lactobacillus-Enterococcus group, Faecalibacterium prausnitzii subgroup, and Bifidobacterium genus. The stimulation of the Clostridium coccoides-Eubacterium rectale cluster depended on the women's equol excretion and was transient, with the exception of a prolonged bifidogenic effect. Lasting changes in the diversity of the dominant species were also observed. The probiotic strain supplied could be detected by TTGE during its passage through the intestinal tract, and ingestion of fructooligosaccharides triggered a marked and specific bifidogenic effect. In conclusion, this is the first human study that shows changes in the diversity and composition of dominant bacterial communities in response to dietary supplementation with hormone-related compounds combined with functional foods.
- 1 December 2005
- Published by Elsevier in The Journal of Nutrition
- Vol. 135 (12) , 2786-2792
Open AccessIsoflavones and Functional Foods Alter the Dominant Intestinal Microbiota in Postmenopausal Women
Dietary phytoestrogens, such as isoflavones, are used as food additives to prevent menopause-related disorders. In addition to other factors, their bioavailability strongly depends on the activity of intestinal bacteria but the underlying interactions remain poorly understood. A randomized, double-blind, placebo-controlled study was undertaken with 39 postmenopausal women to characterize changes in the dominant microbial communities of the intestinal tract after 2 mo of isoflavone supplementation with and without pro- or prebiotic. The diversity and composition of the dominant microbiota were analyzed by temporal temperature-gradient gel electrophoresis (TTGE) and fluorescent in situ hybridization. Isoflavones alone stimulated dominant microorganisms of the Clostridium coccoides-Eubacterium rectale cluster, Lactobacillus-Enterococcus group, Faecalibacterium prausnitzii subgroup, and Bifidobacterium genus. The stimulation of the Clostridium coccoides-Eubacterium rectale cluster depended on the women's equol excretion and was transient, with the exception of a prolonged bifidogenic effect. Lasting changes in the diversity of the dominant species were also observed. The probiotic strain supplied could be detected by TTGE during its passage through the intestinal tract, and ingestion of fructooligosaccharides triggered a marked and specific bifidogenic effect. In conclusion, this is the first human study that shows changes in the diversity and composition of dominant bacterial communities in response to dietary supplementation with hormone-related compounds combined with functional foods.
- 29 March 2005
- Published by Wiley in Environmental Microbiology
- Vol. 7 (7) , 933-946
Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota
Summary: Among human faecal bacteria, many members of the Clostridium leptum subgroup are fibrolytic and butyrate producing microorganisms thereby contributing to processes important to colonic health. Yet this phylogenetic subgroup remains poorly described to date. To improve detection and description of members of the C. leptum subgroup, the Clep 866 group probe was developed. Its association with probes targeting the Clostridium viride cluster (Cvir 1414) and Eubacterium desmolans species (Edes 635) allowed for the first time the detection of all members found in this phylogenetic group in human faecal microbiota. A species‐specific probe was also designed to detect members of the Ruminococcus callidus species (Rcal 733). The design of signature regions was based on alignment of 16S rRNA sequences isolated from faeces of five healthy adults. Furthermore, an oligonucleotide competitor strategy was developed in order to improve the specificity of the probes formerly validated or designed in this study. The oligonucleotide probes were tested using a collection of target and non‐target strains using FISH combined with flow cytometry. These new probes were added to a panel of 18 phylogenetic probes selected to describe faecal microbiota composition in 21 human faeces of healthy adults. Clostridium leptum subgroup represented 22% of the total faecal bacteria and codominated with members of Clostridium coccoides group. The cluster Faecalibacterium prausnitzii was the dominant component of the C. leptum subgroup and 20% of the latter subgroup remained unidentified at the species level.
- 29 March 2005
- Published by Wiley in Environmental Microbiology
- Vol. 7 (7) , 933-946
Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota
Summary: Among human faecal bacteria, many members of the Clostridium leptum subgroup are fibrolytic and butyrate producing microorganisms thereby contributing to processes important to colonic health. Yet this phylogenetic subgroup remains poorly described to date. To improve detection and description of members of the C. leptum subgroup, the Clep 866 group probe was developed. Its association with probes targeting the Clostridium viride cluster (Cvir 1414) and Eubacterium desmolans species (Edes 635) allowed for the first time the detection of all members found in this phylogenetic group in human faecal microbiota. A species‐specific probe was also designed to detect members of the Ruminococcus callidus species (Rcal 733). The design of signature regions was based on alignment of 16S rRNA sequences isolated from faeces of five healthy adults. Furthermore, an oligonucleotide competitor strategy was developed in order to improve the specificity of the probes formerly validated or designed in this study. The oligonucleotide probes were tested using a collection of target and non‐target strains using FISH combined with flow cytometry. These new probes were added to a panel of 18 phylogenetic probes selected to describe faecal microbiota composition in 21 human faeces of healthy adults. Clostridium leptum subgroup represented 22% of the total faecal bacteria and codominated with members of Clostridium coccoides group. The cluster Faecalibacterium prausnitzii was the dominant component of the C. leptum subgroup and 20% of the latter subgroup remained unidentified at the species level.
- 30 April 2003
- Published by Elsevier in Gastroenterology
- Vol. 124 (4) , A478-A479
Differences, in human, between the bacterial communities of the cecum and the feces: a study using direct analysis of 16S rRNA genes
- 30 April 2003
- Published by Elsevier in Gastroenterology
- Vol. 124 (4) , A478-A479
Differences, in human, between the bacterial communities of the cecum and the feces: a study using direct analysis of 16S rRNA genes
- 30 April 2003
- Published by Elsevier in Gastroenterology
- Vol. 124 (4) , A477-A478
Molecular study of the ileal and colonic mucosa associated flora in IBD
- 30 April 2003
- Published by Elsevier in Gastroenterology
- Vol. 124 (4) , A477-A478
Molecular study of the ileal and colonic mucosa associated flora in IBD
- 30 April 2003
- Published by Elsevier in Gastroenterology
- Vol. 124 (4) , A204-204
Molecular inventory of faecal microbiota in patients with Crohn's disease
- 30 April 2003
- Published by Elsevier in Gastroenterology
- Vol. 124 (4) , A204-204
Molecular inventory of faecal microbiota in patients with Crohn's disease
- 1 September 2002
- Published by Elsevier in Digestive and Liver Disease
- Vol. 34, S19-S24
Gastrointestinal tract and the elderly: functional foods, gut microflora and healthy ageing
- 1 September 2002
- Published by Elsevier in Digestive and Liver Disease
- Vol. 34, S19-S24
Gastrointestinal tract and the elderly: functional foods, gut microflora and healthy ageing
- Open Access
- 1 March 2002
- Published by Co-Action Publishing in Microbial Ecology in Health and Disease
- Vol. 14 (1)
Molecular Analysis of Intestinal Microbiota Composition to Evaluate the Effect of PEG and Lactulose Laxatives in Humans
Methods using bacteriological cultures allow only 30–50% of colonic bacterial populations to be detected. Our aim was to assess the effect of osmotic laxative administration on fecal bacteria during chronic idiopathic constipation, by a culture-independent molecular method. Forty-eight constipated patients were included in a randomized blinded trial and received either polyethylene glycol (PEG, n=23) or lactulose (n=25) for 28 days. Non-fermentable laxative (PEG) should not affect the bacterial groups, whereas fermentable (lactulose) could modulate them. The treatment dosage was 20 g per day for a 7-day period, then adjusted according to ef? cacy for 7 days and constant from 10 to 30 g per day for 14 days. Stools were collected at d0, d21 and d28, and analyzed by quantitative dot-blot hybridization using 16S ribosomal RNA-targeted oligonucleotide probes. We used a new Bifidobacterium group specific probe and five other probes to monitor the dominant groups of the intestinal bacteria: Bacteroides -Prevotella-Porphyromonas, Lactobacillus -Enterococcus- Streptococcus, enterobacteria: Clostridium coccoides and Clostridium leptum. Lactulose and PEG administration were associated with an increase of bifidobacterial rRNA index in 72% (18/25) and 17% (4/23) of cases, respectively. In the lactulose group, bifidobacterial rRNA index increased from [mean (SEM)] 1.1% (0.2%) at d0 (a), to 4.3% (1.2%) at d21 (b) and 4.5% (1.1%) at d28 (b), (a≠b, p=0.011). Lactulose treatment when administered at doses usually prescribed for constipation selectively stimulated bifidobacteria within the intestinal microbiota. The quantitative rRNA dot-blot hybridization method is an efficient tool to quantify intestinal bacteria, without the limitations of classical culture methods. Keywords: constipation, lactulose, quantitative dot-blot hybridization, Bifidobacterium probe, 16S rRNA.
- 1 March 2002
- Published by Co-Action Publishing in Microbial Ecology in Health and Disease
- Vol. 14 (1)
Open AccessMolecular Analysis of Intestinal Microbiota Composition to Evaluate the Effect of PEG and Lactulose Laxatives in Humans
Methods using bacteriological cultures allow only 30–50% of colonic bacterial populations to be detected. Our aim was to assess the effect of osmotic laxative administration on fecal bacteria during chronic idiopathic constipation, by a culture-independent molecular method. Forty-eight constipated patients were included in a randomized blinded trial and received either polyethylene glycol (PEG, n=23) or lactulose (n=25) for 28 days. Non-fermentable laxative (PEG) should not affect the bacterial groups, whereas fermentable (lactulose) could modulate them. The treatment dosage was 20 g per day for a 7-day period, then adjusted according to ef? cacy for 7 days and constant from 10 to 30 g per day for 14 days. Stools were collected at d0, d21 and d28, and analyzed by quantitative dot-blot hybridization using 16S ribosomal RNA-targeted oligonucleotide probes. We used a new Bifidobacterium group specific probe and five other probes to monitor the dominant groups of the intestinal bacteria: Bacteroides -Prevotella-Porphyromonas, Lactobacillus -Enterococcus- Streptococcus, enterobacteria: Clostridium coccoides and Clostridium leptum. Lactulose and PEG administration were associated with an increase of bifidobacterial rRNA index in 72% (18/25) and 17% (4/23) of cases, respectively. In the lactulose group, bifidobacterial rRNA index increased from [mean (SEM)] 1.1% (0.2%) at d0 (a), to 4.3% (1.2%) at d21 (b) and 4.5% (1.1%) at d28 (b), (a≠b, p=0.011). Lactulose treatment when administered at doses usually prescribed for constipation selectively stimulated bifidobacteria within the intestinal microbiota. The quantitative rRNA dot-blot hybridization method is an efficient tool to quantify intestinal bacteria, without the limitations of classical culture methods. Keywords: constipation, lactulose, quantitative dot-blot hybridization, Bifidobacterium probe, 16S rRNA.
- 1 January 2002
- Published by Taylor & Francis in Microbial Ecology in Health and Disease
- Vol. 14 (4) , 203-210
Molecular Characterization and Spatial Analysis of a Simplified Gut Microbiota Displaying Colonization Resistance against Clostridium difficile
- 1 January 2002
- Published by Taylor & Francis in Microbial Ecology in Health and Disease
- Vol. 14 (4) , 203-210
Molecular Characterization and Spatial Analysis of a Simplified Gut Microbiota Displaying Colonization Resistance against Clostridium difficile
- 1 September 2001
- Vol. 25, C74-8
[Molecular analysis of the colonic microflora].
- 1 March 1998
- Published by Elsevier in Systematic and Applied Microbiology
- Vol. 21 (1) , 65-71
Design and Evaluation of a 16S rRNA-Targeted Oligonucleotide Probe for Specific Detection and Quantitation of Human Faecal Bacteroides Populations
- 1 March 1998
- Published by Elsevier in Systematic and Applied Microbiology
- Vol. 21 (1) , 65-71
Design and Evaluation of a 16S rRNA-Targeted Oligonucleotide Probe for Specific Detection and Quantitation of Human Faecal Bacteroides Populations